TARGETWATCH
DEDevyser
Latest price
65.30 SEK
22/07/2026
Latest
90.00 SEK
+37.83%
Upside
DVYSR
3 mo+37.83%1 price targets
6 mo+94.49%2 price targets
1 yr+94.49%2 price targets
Max 4 price targets
Pareto Securities
HealthcareMedical Devices

About The Company

Devyser Diagnostics AB (publ) provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa. It offers kits and reagents, such as post-transplantation, thalassemia, fetal RHD screening NIPT, Cystic fibrosis cardiovascular diseases, male infertility, rapid aneuploidy analysis, accessories, hereditary cancer, and transfusion medicine products; and Amplicon Suite and Advyser for cloud-based software solutions for data analysis and the interpretation of test results. The company was incorporated in 2004 and is headquartered in Årsta, Sweden.
Yahoo Finance

Latest Target

Target
90.00 SEK
Upside
+37.83%
Latest price65.30 SEK

Insider Trades for Devyser

Buy
May 2297K SEKJan WahlströmCEO
Buy
May 21190K SEKJan WahlströmCEO

More Price Targets for Devyser

Date
Jul 21
Target
90.00 SEK

Analyst
Date
Feb 13

Analyst
Date
Jul -25

Date
Jul -25